Eli Lilly and Company (LLY · NYSE)
LLY · MARKET VIEW
Market view · as of Aug 10, 2026
Revenue (TTM)
$79.67B
+47.7% YoY
Gross margin
83.4%
EPS (latest q)
$8.38
vs $6.01 est · beat
52-wk position
91.9%
-4.0% vs 52w high · -0.2% 1mo
Price (last ~year)
Eli Lilly and Company (LLY) reports a 47.7% year-over-year revenue increase, with trailing twelve-month revenue reaching $79.67 billion and a market capitalization of $1.06 trillion. The firm has exceeded earnings estimates in each of the last four quarters, most recently posting $8.38 per share for the period ending June 30, 2026, against an estimate of $6.01. The company maintains a financial profile characterized by an operating margin of 54.2% and a debt-to-EBITDA ratio of 1.3x.
Valuation
- Market cap
- $1.06T
- P/E
- 39.84
- PEG
- 1.492
- P/B
- 31.2
- P/S
- 13.27
- EV/EBITDA
- 26.44
- Beta
- 0.506
- Analyst target
- $1297.31
Quality & returns
- Gross margin
- 83.4%
- Operating margin
- 54.2%
- Profit margin
- 33.5%
- ROE
- 102.3%
- ROA
- 20.4%
Price movement
- Last
- $1185.71
- 1-month
- -0.2%
- 3-month
- +20.0%
- RSI (14)
- 57
- vs SMA200
- +15.0%
- 52-wk position
- 91.9% -4.0% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $22.97B | $8.98B | $7.09B | $9.25B |
| 2026-03-31 | $19.80B | $8.85B | $7.40B | $9.69B |
| 2025-12-31 | $19.29B | $8.78B | $6.64B | $8.39B |
| 2025-09-30 | $17.60B | $8.39B | $5.58B | $7.88B |
Recent news
- Somewhat-Bullish Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs · 2026-08-09
- Neutral Amgen Inc. (AMGN) Stock forecasts · 2026-08-09
- Somewhat-Bullish Vertex Pharmaceuticals Incorpor (VRTX) Stock forecasts · 2026-08-09
- Neutral H&R Block, Inc. (HRB) Stock Forecasts · 2026-08-08
- Somewhat-Bullish Linde plc (LIN) Stock Forecasts · 2026-08-08
- Neutral iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? · 2026-08-08
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)